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Maternalobesityduringpregnancyhasbeenlinkedtoanincreasedriskofobesityandcardiometabolic
disease in the offspring, a phenomenon attributed to developmental programming. Programming
effects may be transmissible across generations through both maternal and paternal inheritance,
although themechanisms remainunclear. Using amousemodel,weexplored the effects ofmoderate
maternaldiet-inducedobesity(DIO)onweightgainandglucose-insulinhomeostasis infirst-generation
(F1) and second-generation offspring. DIO was associated with insulin resistance, hyperglycemia and
dyslipidemia before pregnancy. Birthweightwas reduced in female offspring ofDIOmothers (by 6%,
P .039), and DIO offspringwere heavier than controls at weaning (males by 47%, females by 27%),
however there were no differences in glucose tolerance, plasma lipids, or hepatic gene expression at
6 months. Despite the relative lack of effects in the F1, we found clear fetal growth restriction and
persistentmetabolicchangesinotherwiseunmanipulatedsecond-generationoffspringwitheffectson
birthweight, insulin levels, andhepaticgeneexpression thatwere transmitted throughbothmaternal
andpaternal lines.Thissuggeststhattheconsequencesofthecurrentdietaryobesityepidemicmayalso
have an impact on the descendants of obese individuals, evenwhen the phenotype of the F1 appears
largely unaffected. (Endocrinology 154: 2514–2524, 2013)
The prevalence of obesity and its associated metabolicdisorders such as type 2 diabetes is increasing world-
wide (1). This affects women of childbearing age; indeed,
a recent survey in the United States reported that 32% of
women aged 20 to 4 years are obese (World Health Or-
ganization 2009). Adverse maternal environments during
pregnancy, for example, undernutrition or exposure to
stress or glucocorticoids or to inflammatory diseases,
which all associate with restricted fetal growth, have re-
peatedly been linked to increases in the offspring’s risks of
cardiometabolic and neuropsychiatric disorders, a phe-
nomenon attributed to developmental programming (2).
Maternal obesity has well-recognized short-term compli-
cations for both mother and child (3), although it is com-
monly associated with fetal overgrowth rather than
growth restriction (4). Some data have associated mater-
nal obesity with later obesity and cardiometabolic risk
(glucose/insulin homeostasis, hypertension, and vascular
dysfunction) in offspring (5), raising the possibility that
maternal obesity induces developmental programming of
the offspring.
In human studies, it is often difficult to determine to
what extent adverse effects on the health of offspring are
due to shared genes, exposure to an adverse environment
inutero (includingmaternal diabetes), and/or the effects of
postnatal lifestyle factors (ie, maternal overfeeding) (6).
Animal models have provided some evidence that mater-
nal obesity and/or theuseof ahigh-fat cafeteria diet during
pregnancy changes offspring body composition, glucose-
insulin homeostasis, andbloodpressure (reviewed inRefs.
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5, 7, and 8).However, the extent of reported effects differs
substantially between studies (9). The mechanisms by
whichmaternal obesitymight associatewith programmed
changes in the offspring include alteration in the develop-
ment of key organs, eg, liver, muscle, adipose tissue, and
pancreas (5, 10–12), altered appetite circuitry (12), and
changes in leptin levels (13).
Evidence both from human and from animal studies
suggests that programmed changes may not be limited to
the directly exposed first-generation (F1) but may be
transmitted to subsequent generations without re-expo-
sure (14–18). In humans, data fromOverkalix in northern
Sweden suggest that grandparental overnutrition during
the prepubertal period associates with increased cardio-
vascular disease risk in grandchildren (19), although this
appears to reflect more a grandpaternal than a grandma-
ternal effect. Moreover, grandchild obesity is linked to
grandparental obesity independent of parental weight
(20). The transmission of programmed effects to subse-
quent generationshasbeen reported inanumberof animal
models including prenatal glucocorticoid overexposure
(14, 21), maternal undernutrition (18, 22, 23), neonatal
overnutrition (24), and maternal overnutrition (25).
These effects may be transmissible through bothmaternal
and paternal lines (14, 18, 23, 24, 26). Although initial
studies suggested that programmed effects occurring as a
result of an insult in one generation may result in similar
phenotypes in successive generations (14, 23), emerging
evidence suggests that the effects in subsequent genera-
tions may differ from those seen in the F1 who were ex-
posed directly to an insult in utero (21, 26). Indeed, we
have demonstrated parent-of-origin–specific effects on fe-
tal and placental growth and gene expression in a second-
generation (F2) of animals after in utero glucocorticoid
overexposure (14, 21). In this study, we used a model of
moderate maternal diet-induced obesity (DIO) to explore
effects on postnatal weight gain and glucose-insulin ho-
meostasis in the first- and F2 offspring.
Materials and Methods
Animal model
For all studies, animals were maintained under conditions of
controlled lighting (lights on 7:00 AM to 7:00 PM) and tempera-
ture (22°C) and allowed free access to food. All studies were
conducted under licensed approval by the United Kingdom
Home Office, under the Animals (Scientific Procedures) Act,
1986, and with local ethical committee approval.
Model of maternal obesity
Female C57BL/6 mice were bred in house and, at 5 weeks of
age, placed on a high-fat/high-sugar cafeteria diet (DIO: 58%
kcal fat, 25.5% kcal carbohydrate as sucrose; Diet D12331) or
matched control diet (CON: 10.5% kcal fat and 73.1% kcal
carbohydrate as corn starch; Diet D12328) (both fromResearch
Diets, New Brunswick, New Jersey). Details of dietary constit-
uents are given in Supplemental Table 1 (published on The En-
docrine Society’s Journals Online web site at http://endo.endo-
journals.org). At 17weeks of age, 1 group of females underwent
ip glucose tolerance testing and were killed; tissues were dis-
sected, weighed, and snap frozen. A second group was time-
mated with C57BL/6 males that had been maintained on stan-
dard laboratory chow (RMI 801002; Special Diets Services,
Witham, Essex, United Kingdom). Groups of pregnant females
either had ip glucose tolerance testing performed at gestational
day 18.5 and were then killed and tissues collected or were al-
lowed to litter undisturbed. Females remained on their experi-
mental diets through pregnancy and lactation. Dietary intake
was estimated by weighing food.
F1 offspring
At postnatal day 1, litters were weighed and culled to 5; only
litters from females that had remained undisturbed during preg-
nancy were studied. Animals remained with their mothers until
weaning at 3 weeks when they were placed onto standard chow
diet (RMI 801002; Special Diets Services). Groups of offspring
(1 male and 1 female pup per litter) were individually housed at
6 months (males, F1 DIO n  10 and F1 CON n  6; females,
F1 DIO n 5 and F1 CON n 6) and left to acclimatize for at
least 5daysbeforeundergoingglucose tolerance testing.Animals
were killed 7 to 10 days later, and tissues were dissected,
weighed, and snap-frozen on dry ice.
F2 offspring
F2 offspring were generated by timedmating of F1males and
females at 12 weeks of age, all on standard chow diet as above.
Animals were mated in all combinations to give 4 groups of F2
offspring: 1) offspring from F1 CONmother and father (mater-
nal CON [mCON]/paternal CON [pCON], n  11 litters), 2)
offspring from F1 CON mother and F1 DIO father (mCON/
pDIO,n8 litters), 3) offspring fromF1DIOmotherF1CON
father (mDIO/pCON, n  9 litters), and 4) offspring from F1
DIOmother and father (mDIO/pDIO, n9 litters). F2 offspring
were weighed at birth and remained with their mother for 3
weeks after which they were weaned onto standard chow and
weighed monthly. After glucose tolerance testing at 6 months,
offspring were killed and tissues dissected and weighed.
Plasma measurements
Intraperitoneal glucose tolerance testswere performed after a
6-hour fast. A fasting tail nick blood sample was taken imme-
diately before glucose injection and within 1 minute of cage dis-
turbance, after which mice received an ip injection of glucose (2
g/kgbodyweight).Tail bloodwas taken intoEDTA-coated tubes
at 15, 30, 60, and 90minutes after glucose injection. Blood sam-
ples were placed on ice and centrifuged at 2.3g for 10 minutes at
4°C, and plasma was stored at 20°C. Plasma glucose levels
were determined by the hexokinase/glucose-6-phosphate dehy-
drogenase method (Thermo Fisher Scientific, Loughborough,
United Kingdom) and plasma insulin by ELISA (Crystal Chem
Inc, Downers Grove, Illinois). Plasma triglyceride (fasting) and
cholesterol levels were measured using an enzymatic assay fol-
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lowing the manufacturer’s instructions (Infinity kits; Thermo
Fisher Scientific). Plasma corticosterone concentrations were
measured as previously described (27).
Quantification of mRNA by real-time PCR
Total RNA was extracted from snap-frozen liver using an
RNeasy mini kit (QIAGEN, Crawley, United Kingdom) follow-
ing the manufacturer’s instructions. Total RNA (500 ng) was
reverse transcribed using a Promega reverse transcription kit
(Promega United Kingdom Ltd, Southampton, United King-
dom).Real-timePCRwasperformedusing either theUPLsystem
from Roche Diagnostics Ltd (Burgess Hill, United Kingdom) or
predesigned assays from Applied Biosystems (Warrington,
UnitedKingdom),using theRocheLightCycler480aspreviously
described (28). Primer sequences and assay details are listed in
SupplementalTable2.Resultswerenormalized to the expression
of the housekeeping gene cyclophilin (Applied Biosystems gene
expression assay Mm02342430_gl).
Measurement of hepatic
triglyceride content
Liver tissue (100 mg) was digested
at 55°C overnight in 10% (wt/vol) po-
tassium hydroxide in ethanol; undi-
gested tissue was removed by centrifuga-
tion at 10 000g for 5 minutes.
Supernatant was removed and mixed
with 1M magnesium chloride (1:1), and
samples were then vortexed, incubated
on ice for 10 minutes, and centrifuged at
10 000g for 5 minutes. The supernatant
wasused tomeasure triglycerideusing an
enzymatic assay following the manufac-
turer’s instructions (Infinity kits;
Thermo Fisher Scientific).
Statistics
Data are expressed as mean  SEM.
Groupswere compared by independent t
Figure 1. A and B, Glucose tolerance tests in nonpregnant and pregnant females at E18.5. DIO
females were both hyperglycemic (A) and hyperinsulinemic (B) before pregnancy. C and D, DIO
females were no longer hyperglycemic (C) but remained hyperinsulinemic (D) at E18.5. Statistical
analysis was by unpaired t tests for areas under the curve; data are mean  SEM for n  6 per
group for nonpregnant and 7 per group for pregnant females. *, P  .05; ***, P  .005.
Table 1. Food Intake, Body and Organ Weights, and Plasma Lipids in Nonpregnant and Pregnant Femalesa
Control Diet (CON) Cafeteria Diet (DIO) P value
Nonpregnant
Food intake/d, g 2.53  0.12 2.77  0.08 .17
Energy intake/d, kcal 10.31  0.51 15.45  0.46 .002
Weight at cull, g 23.32  0.47 35.18  1.13 .0001
Liver weight, g 0.94  0.05 1.15  0.11 .11
Mesenteric fat weight, g 0.16  0.02 0.62  0.07 .01
Subcutaneous fat weight, g 0.16  0.01 0.59  0.11 .001
Retroperitoneal fat weight, g 0.036  0.003 0.18  0.03 .001
Plasma cholesterol, mmol/L 2.18  0.16 3.67  0.21 .001
Plasma triglycerides, mmol/L 0.54  0.03 0.68  0.04 .017
Pregnant
Body weight at mating, g 22.17  0.37 30.16  0.88 .0001
Body weight E10, g 25.21  0.44 32.31  0.99 .006
Body weight E18, g 33.89  0.39 38.34  1.09 .001
Weight gain in pregnancy E1--E18, g 11.72  0.56 8.18  1.12 .006
Food intake E1--E18, g 51.99  1.536 39.17  2.692 .001
Energy intake E1--E18, kcal 207.6  3.6 213.8  12.2 .65
Energy intake/d E1--E18, kcal 11.75  0.35 12.16  0.81 .65
Protein intake E1--E18, g 8.57  0.14 8.84  0.50 .60
Maternal body weight at E18 (uterus removed), g 26.1  1.4 27.8  0.9 .33
Liver weight at E18, g 1.58  0.06 2.15  0.20 .04
Mesenteric fat weight at E18, g 0.19  0.02 0.19  0.01 .12
Retroperitoneal fat weight at E18, g 0.06  0.01 0.11  0.02 .30
Subcutaneous fat weight at E18, g 0.23  0.03 0.36  0.07 .33
Plasma cholesterol at E18, mmol/L 1.41  0.09 2.53  0.17 .001
Plasma triglycerides at E18, mmol/L 0.73  0.02 0.77  0.07 .61
For nonpregnant females, n  6 per group and 7 per group for pregnant females
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tests, 1-way ANOVA with post hoc least significant difference
testing, area under the curve, 2-way ANOVA or repeated-mea-
sures ANOVA as appropriate.
Results
Maternal weight gain and metabolic status
prepregnancy
Nonpregnant females on the cafeteria diet (DIO) con-
sumed more calories than CON (Table 1) and were sig-
nificantly heavier from 7 weeks of age. By 17 weeks, DIO
females were 22.9% heavier than CON with increased
mesenteric, sc, and retroperitoneal fat pad weights (Table
1). DIO females were hyperglycemic (Figure 1A) and hy-
perinsulinemic (Figure 1B) on glucose tolerance testing
andhad increased circulating levels of cholesterol and trig-
lycerides (Table 1).
Maternal dietary intake, weight gain, and
metabolic status during pregnancy
During pregnancy, DIO females consumed the same
number of calories per day as CON females. Although
DIO females were significantly heavier at embryonic day
10.5 (E10.5) and E18.5 (Table 1), by E18.5, once the uteri
containing pups had been removed, there was no longer a
difference in maternal weights between groups. Addition-
ally, there were no longer any significant differences in the
weights of mesenteric, sc, or retroperitoneal fat pads be-
tween thegroupsatE18.5 (Table1).ByE18.5, glucoseand
insulin concentrations were higher in both groups than in
the nonpregnant state; however, glucose levels in pregnant
DIO females were no longer different from CON females
(Figure 1C), although insulin (Figure 1D) and cholesterol
(Table 1) concentrations were still higher in DIO females
compared with CON females.
Effect of maternal obesity on F1 offspring
There was no difference in gestation length (CON
21.2  0.2 vs DIO 20.5  0.3 days, P  .08), although
DIO females had fewer offspring than CON females
(CON 6.5  0.5 pups per litter from 21 litters vs DIO
5.0  0.4 pups per litter from 22 litters, P  .033). Ma-
ternal DIO did not affect birth weight of male offspring
(F1 CON 1.32  0.02 g [62 pups from 21 litters] vs F1
DIO 1.28  0.03 g [38 pups from 22 litters], P  .25);
however, there was a reduction in birth weight of females
(F1 CON 1.28  0.02 g [69 pups from 21 litters] vs F1
DIO1.21 0.03 g [53 pups from22 litters],P .039). By
weaning, both male and female F1 DIO offspring were
significantly heavier than F1 CON offspring (F1 CON
males 8.90  0.56 g [n  31] vs F1 DIO males 13.10 
0.64 g [n  19], P  .001; and F1 CON females 7.87 
0.15 g [n41] vs F1DIO females 10.010.17 g [n42],
P  .0001); however, this weight difference did not per-
sist, so that at 3 and 6 months of age, there were no dif-
ferences in body weight in male F1 DIO offspring, and
indeed, female F1 DIO offspring were lighter than F1
CON at 6months (Figure 2). There were no differences in
food intake between F1 CON and F1 DIO offspring in
either sex (F1 CON males 3.65  0.06 vs F1 DIO males
3.83  0.07 g/d, P  .08; and F1 CON females 3.11 
0.04 vs F1 DIO females 3.09  0.07 g/d, P  .76). No
differenceswere found in organweights, including fat pad
weight, in either sex at 6 months (Supplemental Table 3).
Maternal DIO had no effects on plasma glucose or in-
sulin concentrations during glucose tolerance testing (Fig-
ure 3) or on plasma triglyceride or cholesterol levels at 6
months in male or female F1 offspring (Supplemental Ta-
ble 3). We analyzed expression of key genes implicated in
programming effects in F1 offspring liver at 6 months of
age. These included genes important in glucose and lipid
metabolism (lipoprotein lipase [LPL], phosphoenolpyru-
vate carboxykinase [PEPCK] and peroxisome prolifera-
tor-activated receptor [PPAR]- [PPAR]) and genes in-
volved in glucocorticoid signaling and metabolism
(glucocorticoid receptor [GR], 5-reductase [5r], 5-re-
ductase [5r], and 11-hydroxysteroid dehydrogenase
type 1 [Hsd11b1]). Therewere no effects ofmaternal DIO
on hepatic gene expression in either male (Figure 4A) or
female (Figure 4B) F1 offspring at 6 months of age.
Effects on F2 offspring
The F1 offspring of DIO and CON mothers, without
any further manipulations, were mated in all combina-
tions to generate a second generation of offspring. There
were no differences in litter numbers or gestation length in
any group. To determine any differences between F2 off-
spring groups, initial analysis was performed by 1-way
Figure 2. Postweaning body weight in F1 offspring of lean and obese
females. Both male and female F1 offspring of DIO mothers were
heavier than controls at weaning (3 weeks). However, by 6 months,
there were no differences in weight in males, whereas female
offspring of DIO mothers were lighter than offspring of CON mothers.
Data are mean  SEM and were analyzed by repeated-measures
ANOVA. *, P  .05 (n  5–10 per group).
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ANOVA. Birth weight was reduced in all male DIO F2
offspring groups comparedwithmCON/pCONoffspring
(Table 2; F  3.61, P  .015). Among female offspring,
birth weight was lower in mDIO/pDIO F2 offspring com-
paredwithmCON/pCON(Table 2;F3.39,P .02).At
weaning, there had been catch-up growth in the lower-
birth-weight DIO F2 groups such that there were no per-
sisting group differences inweight in eithermale or female
pups (Table 2).At 6months of age, although therewere no
differences in body weight in F2 male offspring (Table 2),
there was an increase in the weight of sc adipose tissue in
mDIO/pDIO andmDIO/pCONmale offspring compared
withmCON/pCON (Table 2; F 3.43,P .03). Addition-
ally, in theF2males, plasma cholesterolwas lower inmDIO/
pCON and mCON/pDIO compared with mCON/pCON
offspring (Table 2; F  3.89, P  .002). In F2 female off-
spring at 6 months of age, there were no differences in body
weight, organ weight, or lipid profile (Table 2).
Recent data suggest that the exposure status of either
parent might contribute to the phenotype of F2 offspring,
with studies showing that the effects of prenatal gluco-
corticoid overexposure and prenatal undernutrition can
be transmissible to the F2 through either maternal or pa-
ternal lines (21, 29). Thus, to determine the contribution
to the F2 phenotype that might be attributable to either
maternal or paternal early-life expo-
sure to obesity and, additionally,
whether there was any interaction
between these 2 variables, data were
further analyzed by 2-way ANOVA.
We foundaneffect ofmaternal early-
life exposure to obesity to decrease
birth weight in F2 males (Table 2;
maternal effect F  4.30, P  .05)
andof paternal early-life exposure to
obesity todecrease birthweight inF2
females (Table 2; paternal effect F
8.77, P  .01). At 6 months of age,
analysis of parental effects revealed
an effect of maternal early-life expo-
sure to obesity specifically in male
offspring to increase the weight of
mesenteric (F  4.93, P  .05), sc
(F  9.87, P  .01), and retroperi-
toneal (F  4.93, P  .05) adipose
tissue (Table 2). There was also an
effect ofmaternal early-life exposure
to increase insulin levels during glu-
cose tolerance testing in male off-
spring, with the highest insulin re-
sponses to a glucose load in offspring
of mothers exposed to obesity in
early life (F2 male mDIO/pDIO and F2 male mDIO/
pCON; Figure 5B; F  9.36, P  .01). In contrast, in F2
females, there was an interaction between maternal and
paternal early-life exposure to obesity to reduce insulin
levels during glucose tolerance testing, with the lowest
insulin responses in F2 female mDIO/pCON andmCON/
pDIO offspring (Figure 5D; F  5.47, P  .05).
We initially analyzed thehepatic expressionof the same
genes studied in the F1 generation; however, after a num-
ber of significant differences were identified, we extended
the analysis to include a number of other genes implicated
in hepatic lipid metabolism (acetyl coenzyme-A carboxy-
lase [ACC], carnitine palmitoyltransferase 1a, PPAR- co-
activator 1 [PGC1], fatty acid synthase [FAS], and
PPAR). Initial analysis of gene expression to identify dif-
ferences between groups using 1-way ANOVA revealed
effects in both male and female F2 offspring at 6 months
of age. Inmales, mRNA encoding PPAR,ACC, PGC1,
FAS, and GR was reduced in all DIO groups compared
with mCON/pCON (PPAR: F  3.36, P  .03; ACC:
F 36.81, P .001; PGC1: F 10.90, P .001; FAS:
F 8.53, P .001;GR: F 5.81, P .004) (Figure 6A).
In female offspring, there were significant differences in
the expression of PPAR (reduced in mDIO/pCON: F 
4.52, P  .03), LPL (reduced in mDIO/pCON and
Figure 3. Glucose tolerance tests in F1 offspring males and females at 6 months of age. A,
Plasma glucose. B, Plasma insulin. There was no statistically significant difference in plasma
glucose or insulin concentrations between groups in male or female offspring. Data are mean 
SEM and were analyzed by unpaired t tests for areas under the curve (n  5-10 per group).
2518 King et al Multigenerational Effects of Maternal Obesity Endocrinology, July 2013, 154(7):2514–2524
The Endocrine Society. Downloaded from press.endocrine.org by [${individualUser.displayName}] on 10 February 2015. at 02:09 For personal use only. No other uses without permission. . All rights reserved.
mCON/pDIO: F  4.52, P  .01), PGC1 (reduced in
mDIO/pCON and mCON/pDIO: F  3.48, P  .03),
PEPCK (reduced in all groups compared with mCON/
pCON: F  5.94, P  .03), and GR (reduced in mCON/
pDIO: F  5.29, P  .005) (Figure 6B).
To analyze any effect of maternal or paternal early-life
exposure to obesity on gene expression, data were rean-
alyzed using 2-way ANOVA. In male offspring, there was
an effect of maternal early-life exposure to obesity to re-
duce the expression of PPAR (F  4.49, P  .04), FAS
(F  5.78, P  .024), ACC (F  35.36, P  .001), and
PGC1 (F  9.02, P  .006) and an effect of paternal
early-life exposure to obesity to reduce the expression of
FAS (F  10.57, P  .03), ACC (F  42.08, P  .001),
PGC1 (F  11.4, P  .002), and GR (F  12.18 P 
.002). In female F2 offspring, there was an interaction
betweenmaternal and paternal early-life exposure to obe-
sity to reduce the expression of LPL (F 9.23 P .005),
PEPCK (F  11.98 P  .002), PPAR (F  10.18 P 
.003), PGC1 (F 10.26, P .004),GR (F 12.6 P
.001), and 5r (F 4.67 P .04). In view of the changes
in the expression of genes involved in
hepatic lipid metabolism in both
sexes, we also quantified hepatic
triglyceride content in the F2 off-
spring; however, there were no dif-
ferences between groups in either
sex (Table 2).
Discussion
Here we show that moderate mater-
nal dietary obesity, sufficient to
cause modest insulin resistance, hy-
perglycemia, and dyslipidemia, and
which causes relatively few effects in
her immediate offspring, nonethe-
less produces clear fetal growth re-
striction and persisting metabolic ef-
fects in the otherwise unexposed F2
via both maternal and paternal in-
heritance. These data echo the strik-
ing, if limited, human epidemiologi-
cal findings from the Overkalix
study (19) and suggest that the con-
sequences of the current dietary obe-
sity epidemic may have an impact
well beyond the direct effects in
obese individuals.
Previous studies have reported in-
consistent findingswith respect to ef-
fects on glucose and insulin homeo-
stasis in offspring of mothers consuming a high-fat diet
throughout pregnancy and lactation (9), with a number of
studies reporting only transient effects on offspring glu-
cose and insulin levels (30, 31). The inconsistencies be-
tween studies have been highlighted in a recent systematic
review (9). Experiments have differed in terms of species
(rat and mouse) and strain of animal used and the length
of time females were exposed to the diet before mating.
This is likely to be important in determining the extent of
maternal metabolic dysfunction and thus offspring out-
come (32). Importantly, the types of diet used and the
dietary constituents have differed between studies; some
have used diets only high in fat content (with the type of
fat differing between studies), or high-fat combined with
high-sugar cafeteria diets (9). Notably, many studies have
used standard chow as the control diet, which may addi-
tionally differ from the experimental diet in both macro-
and micronutrient content. We used a cafeteria diet that
was high in both sucrose and fat, because the content of
bothmacronutrients is higher in the diets of obesewomen.
Figure 4. Gene expression analysis in liver from 6-month-old F1 offspring. There were no
differences between offspring of DIO and CON mothers in hepatic mRNA expression in F1 males
(A) or females (B). Data are mean  SEM and were analyzed by unpaired Student’s t testing
(n  7-8 per group).
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The control diet was matched for protein and micronu-
trient content to minimize variation in maternal nutri-
tional intake between groups and additionally to avoid
low protein intake in the cafeteria diet group during preg-
nancy, which is important given the known programming
effects of prenatal exposure to a low-protein diet (33).
Cafeteria-fed females were heavier, with increased fat pad
weights, hyperinsulinemia, hyperglycemia, and hyperlip-
idemia before pregnancy. Although the weights and met-
abolic status of control and cafeteria-fed females are con-
sistent with those in previous studies using different diets,
which report effects on offspring bodyweight, appetite, glu-
cose-insulin homeostasis, and blood pressure (12), we ob-
served few effects on F1 offspring phenotype in this model.
Future studies are required to determine the role of different
dietary constituents and the time at which the maternal diet
is introduced in determining offspring outcome.
In late gestation, glucose and insulin concentrations
increased in both control and cafeteria-fed females com-
pared with nonpregnant females, consistent with the de-
cline in insulin sensitivity that normally takes place during
pregnancy (34). However, this occurred to a lesser extent
in cafeteria-fed females, so that although they remained
hyperinsulinemic relative to controls, they were no longer
hyperglycemic or hypertriglyceridemic. Additionally,
whereas cafeteria-fed females consumedmore calories per
day than controls in the nonpregnant state, during preg-
nancy, there was no difference in calorie intake between
groupsandgestationalweight gain in cafeteria-fed females
was less than that in controls. This reduction in maternal
weight gain was not solely due to the reduced litter size in
the DIO group because there were no persistent differ-
ences in maternal weight or fat pad mass when the uteri
were removed. We propose that the lack of difference in
calorie intake in pregnancy and the decreased gestational
weight gain in DIO females may account, at least in part,
for the improvement in metabolic phenotype of the DIO
females and may be of critical importance in limiting the
metabolic consequences for the offspring. Indeed, in hu-
man studies, gestational weight gain has been identified as
an important determinant of cardiometabolic outcome in
young adult offspring, independent of maternal body
mass index (35). Further studies are required to dissect the
precise mechanisms accounting for the reduced gesta-
tional weight gain in cafeteria-fed females and the appar-
ent protection against metabolic consequences in the
offspring.
Birth weight was unchanged in F1 DIO males but de-
creased in F1DIO females; however, therewas evidence of
catch-up growth because both male and female offspring
of obese mothers were heavier than controls at weaning.
Offspring remained with their mothers until weaning so
Table 2. Body and Fat Pad Weights and Plasma Lipids in F2 Offspring
F2 Generation
mCON/pCON
(n  11 litters)
mDIO/pDIO
(n  9 litters)
mDIO/pCON
(n  9 litters)
mCON/pDIO
(n  8 litters)
Mother CON DIO DIO CON
Father CON DIO CON DIO
Males
Birth weight, g (number of pups) 1.34  0.02 (37) 1.26  0.02b (34) 1.26  0.02b (31) 1.27  0.02b (26)
Weaning weight, g (n) 10.31  0.26 (11) 9.97  0.39 (10) 9.83  0.25 (13) 10.28  0.041 (10)
Weight at 6 months, g (n) 34.76  0.63 (11) 35.32  0.95 (10) 37.05  0.72 (13) 34.43  1.15 (10)
Mesenteric fat weight, mg/g (n) 0.82  0.05 (7) 0.90  0.07 (8) 0.95  0.07 (9) 0.73  0.07 (9)
Subcutaneous fat weight, mg/g (n) 0.79  0.08 (7) 1.23  0.14b (8) 1.11  0.11b (9) 0.86  0.09 (9)
Retroperitoneal fat weight, mg/g (n) 0.31  0.05 (7) 0.43  0.05 (8) 0.41  0.04 (9) 0.31  0.04 (9)
Epididymal fat weight, mg/g (n) 0.97  0.14 (7) 1.19  0.11 (8) 1.27  0.07 (9) 1.08  0.12 (9)
Plasma TG, mmol/L (n) 0.54  0.02 (8) 0.47  0.03 (9) 0.65  0.04 (9) 0.63  0.05 (9)
Plasma cholesterol, mmol/L (n) 2.5  0.33 (8) 2.35  0.16 (9) 1.82  0.16b (9) 1.54  0.24b (9)
Hepatic TG (nmol/mg) (n) 17.0  1.4 (6) 17.6  1.3 (5) 16.7  1.8 (6) 18.2  3.1 (5)
Females
Birth weight, g (number of pups) 1.31  0.02 (42) 1.23  0.02b (28) 1.31  0.02 (30) 1.27  0.02 (29)
Weaning weight, g (n) 9.97  0.33 (10) 10.18  0.22 (9) 9.79  0.27 (11) 9.72  0.41 (8)
Weight at 6 months, g (n) 27.10  0.94 (10) 27.08  0.80 (9) 26.66  0.75 (11) 26.10  0.62 (8)
Mesenteric fat weight, mg/g (n) 0.65  0.06 (8) 0.68  0.05 (8) 0.65  0.07 (8) 0.56  0.06 (8)
Subcutaneous fat weight, mg/g (n) 1.15  0.17 (8) 0.94  0.08 (8) 1.05  0.14 (8) 0.88  0.09 (8)
Retroperitoneal fat weight, mg/g (n) 0.34  0.06 (8) 0.34  0.09 (8) 0.29  0.07 (8) 0.19  0.04 (8)
Plasma TG, mmol/L (n) 0.55  0.08 (8) 0.59  0.08 (9) 0.55  0.04 (9) 0.48  0.05 (8)
Plasma cholesterol, mmol/L (n) 1.35  0.40 (8) 1.99  0.28 (9) 1.76  0.24 (9) 1.35  0.22 (8)
Hepatic TG (nmol/mg) (n) 28.1  2.8 (6) 18.8  2.3 (6) 25.9  5.3 (6) 25.7  3.6 (6)
a Organ weight is expressed relative to total body weight. Analysis was performed using 1-way ANOVA.
b Significant differences compared with mCON/pCON.
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that exposure to the cafeteria diet occurred both pre- and
postnatally. The increased postnatal weight gain in F1
DIO offspring may therefore be due to ingestion of milk
that is higher in calorie content and/or increased intake,
since a recent study in rats showed that high-fat–fedmoth-
ers produce milk with a higher fat content than controls
and that their offspring consumemoremilk (36).The early
postnatal period is an important developmental window
for the later programming of disease risk; in animal stud-
ies, early postnatal overnutrition results in obesity, hyper-
tension, and hyperinsulinemia (37–39), and in humans,
rapid weight gain in early infancy is associated with met-
abolic risk factors in young adulthood (40, 41). Never-
theless, despite both pre- and postnatal exposure and this
rapid early postnatal growth in F1 DIOmales, there were
no persistent differences in weight after weaning in male
offspring. There was, however, a sex difference, and al-
though F1 DIO females were heavier at weaning, they
were lighter than F1 CON females at 6 months of age.
Although there were no differences in organ weight, it is
possible that programmed differences in body length (25)
could explain the observedweight differences. Therewere
no effects on metabolic parameters in adulthood in either
sex; whether programmed effects on metabolism might
become evident after a second hit, such as postweaning
exposure to a cafeteria diet (42) or with aging, which has
been associated with a more pronounced programmed
phenotype (43, 44), remains to be explored in this model.
Despite the minimal effects noted in the F1 generation,
there were clear impacts on the F2. Grand-maternal DIO
acting through the maternal line was associated with re-
duced birth weight and with increased fat pad weight,
increased insulin levels, and altered hepatic gene expres-
sion in F2 male offspring, whereas grand-maternal DIO
acting through the paternal line reduced birthweight in F2
females. Additionally, there were marked effects on he-
patic gene expression in F2 offspring, notably with com-
plex sex-specific effects on the expression of enzymes in-
volved in lipidmetabolism. Inmales, parental exposure to
obesity in early life resulted in a decrease in the expression
of enzymes involved in de novo lipogenesis (ACC and
FAS) but also in a decrease in the expression of PPAR,
which would predict increased hepatic lipid accumula-
tion. In females, although parental exposure to obesity in
early life was also associated with decreased PPAR ex-
pression, there was also a decrease in the expression of
LPL, predicting reduced hepatic lipid accumulation. Ad-
ditionally, therewas an effect of parental exposure to obe-
sity in early life to reduce the expression of PEPCK; this
would predict reduced hepatic gluconeogenesis and is an
intriguing finding given that insulin levels were also re-
duced in these groups. The expression of PGC1 was
Figure 5. Glucose tolerance tests in F2 offspring at 6 months of age. A and C, There were no effects on plasma glucose concentrations in F2
males (A) or females (C). B and D, However, there was an effect of maternal early-life exposure to obesity to increase insulin concentrations in F2
male offspring (B) (*a, P  .005) and an interaction between maternal and paternal early life exposure to obesity to reduce insulin levels in F2
females (D) (*b, P  .05). Data are mean  SEM and were analyzed by 2-way ANOVA for areas under the curve (n  8–10 per group).
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affected in both male and female F2 offspring. Altered
hepatic PGC1 expression has been reported in a num-
ber of animal models of programming including expo-
sure to a high-fat diet and excess glucocorticoid prena-
tally (28, 45), and our results suggest that this is also
important in the F2. Nevertheless, despite these changes
in lipid-metabolizing enzymes, there were no changes in
hepatic triglyceride content in either sex.
The transmission of programmed effects to a F2
through both maternal and paternal lines has now been
reported in a number of animal models (14, 17, 18, 46);
however, in most of these studies, there were also obvious
programmed effects in the F1. Delineating multigenera-
tional effects in humans is hampered by the difficulties in
determining the relative importance of environmental/so-
cial/cultural and genetic effects. There is, however, some
evidence for the transmission of effects on birth size and
cardiometabolic risk factors through both maternal and
paternal lines (15, 19, 47–50). Although many of these
studies demonstrate transmission through the female line,
in the Swedish Overkalix cohort, the effects of grandpa-
rental food availability on cardiovascular and diabetes
risk in grand-offspring were transmitted through the pa-
ternal lineage (19).
A number of mechanisms may underlie the transmis-
sion of programmed effects to subsequent generations
(51). Transmission through the ma-
ternal line may occur as a conse-
quence of maternal effects (51), be-
cause females exposed to an adverse
environment in utero may develop
programmed effects such as hyper-
tension (52, 53) or glucose-insulin
dyshomeostasis (54, 55), which may
influence the development of a fetus
(51). In this study, although we
found no overt phenotype in non-
pregnant F1 female offspring, an
inability of females to adapt to preg-
nancy could impact on the develop-
ing F2 fetus. This phenomenon has
been reported in other animal mod-
els of programming (56, 57) andmay
contribute to the familial risk of type
2 diabetes and hypertension in hu-
mans (51). An alternative explana-
tion for the transmission of effects
through the maternal and/or pater-
nal line is through direct effects on
the developing germ cell (58). The
germ cells that will form the F2 gen-
eration are present in the developing
gonad of the F1 offspring during gestation and are there-
fore also exposed to, and potentially affected by, the ab-
normal environment of an obese mother maintained on a
cafeteria diet. Indeed, recent studies have suggested that
environmentally induced epigenetic modificationsmay be
transmissible through the germ line and may be an im-
portant mechanism underlying intergenerational effects
(17, 59–61). The mechanisms by which such effects are
transmitted through the maternal line specifically to sons
and through the paternal line to daughters remain un-
known. Differences in the maturation rates of males and
females may be important, so that exposure to an altered
maternal environment during a critical developmental pe-
riodmayplausibly affect one sexmore than the other (62).
Alternatively, the F1 mothers may have invested differ-
ently in their offspring postnatally, through altered ma-
ternal care behavior, because maternal behavior such as
pup retrieval may be influenced by pup gender and health
(63, 64). However, these mechanisms do not account for
the transmission of effects through the paternal line spe-
cifically to daughters, although a role for effects on sex
chromosomes has been hypothesized (65).
In conclusion, we have shown that maternal obesity/
perinatal exposure to a high-fat, high-sugar diet is not
necessarily associatedwith programmed effects onmetab-
olism in the F1 directly exposed offspring. Nevertheless,
Figure 6. Gene expression analysis in liver from 6-month-old F2 offspring. There were effects on
the expression of GR and PPAR in F2 male offspring (A) and on the expression of LPL, PPAR,
and GR in females (B). *, Significant difference compared with mCON/pCON. Data were
analyzed by one-way ANOVA (n  7–8 per group).
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changes in prenatal growth, body composition, insulin
and lipid levels, and gene expression were present in the
F2, and these effects were both gender- and parent-of-
origin–specific. Although the mechanisms remain to be
determined, these findings, if translated into human stud-
ies, have profound implications for public health.
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